Life After Allogeneic Stem Cell Transplantation Leukemia And

More documents

Recommendations

Info

<strong>Allogeneic</strong> SCT: Relapse• Risk of relapse decreases with time• Risk of relapse is dependent on type of disease• TREATMENT: DLI: Donor Leukocyte Infusion– Used (either with or without chemo) to invokeGraft vs Tumor response with goal of cure• Clinical Trials:– New medications and chemotherapy drugs– New ways to make DLI more effective
Second cancers• Definition: biologically distinct cancer developing afterthe first• Second cancers are of two types: leukemia/MDS andsolid tumors• <strong>Leukemia</strong>s usually occur within the first few years, solidtumors usually much later• When you look at adult survivors, risk is modest 1.3-1.7xgeneral population• Among children survivors, risk is higher but when youlook at all survivors over time the individual risk per yearis rather small; standard screening for ‘screenable’tumors is usually started earlier.
Page 1 and 2: Life After Allogeneic Stem CellTran
Page 3 and 4: Allogeneic Stem CellTransplantation
Page 5 and 6: Allogeneic SCT:Side Effects and Com
Page 7 and 8: The Immediate post-transplanttransp
Page 9 and 10: The “I I should be feeling better
Page 11 and 12: DONORHOSTGVHSkinGut
Page 13 and 14: Acute Graft-vsvs-Host Disease• Sk
Page 15 and 16: Chronic GVHD• Mucous membranes- D
Page 17 and 18: Allogeneic SCT: Infections• Highe
Page 19: Butdon’tcarry ittoo far!
Page 23: Allogeneic SCT: HeartComplications
Page 26 and 27: Life after Transplant• Muscles an
Page 28 and 29: Depression and Anxiety• A certain
Page 30 and 31: Managing Relationships withFriends
Page 32: ResourcesLeukemia & Lymphoma Societ

Life After Allogeneic Stem Cell Transplantation Leukemia And

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?